Structures by: Bright S. A.
Total: 10
C40H23F12N14O0.5P2Ru
C40H23F12N14O0.5P2Ru
Journal of medicinal chemistry (2015) 58, 11 4494-4505
a=9.2489(3)Å b=12.1579(4)Å c=18.0824(6)Å
α=82.455(2)° β=82.843(2)° γ=81.221(2)°
C19H20O6
C19H20O6
Organic & biomolecular chemistry (2019) 17, 25 6184-6200
a=7.7673(2)Å b=8.9291(3)Å c=12.6819(4)Å
α=99.235(2)° β=90.839(2)° γ=93.211(2)°
C18H19N3O3
C18H19N3O3
Organic & biomolecular chemistry (2014) 12, 34 6610-6623
a=5.5440(18)Å b=23.166(8)Å c=12.365(4)Å
α=90.00° β=102.769(4)° γ=90.00°
C19H21N3O2
C19H21N3O2
Organic & biomolecular chemistry (2014) 12, 34 6610-6623
a=6.962(2)Å b=14.046(5)Å c=16.346(6)Å
α=90.00° β=95.843(4)° γ=90.00°
C18H19N3O2
C18H19N3O2
Organic & biomolecular chemistry (2014) 12, 34 6610-6623
a=6.6599(17)Å b=21.310(5)Å c=11.054(3)Å
α=90.00° β=99.174(4)° γ=90.00°
Bis(1,4,5,8-tetraazaphenanthrene)(3-methyl-pyrazino[2,3-h]dipyrido[3,2-a:2?,3?-c]phenazine)ruthenium(II) chloride
C41H24N14Ru,2(Cl)
Dalton transactions (Cambridge, England : 2003) (2016) 45, 45 18208-18220
a=13.41(5)Å b=20.75(7)Å c=21.49(8)Å
α=63.55(6)° β=80.88(6)° γ=88.05(6)°
Bis(1,4,5,8-tetraazaphenanthrene)(dipyrido[3,2-a:2?,3?-c][1,2,5]thiadiazolo [3,4-4,3]phenazine)ruthenium(II) chloride
C38H20N14RuS,2(Cl),6(H2O)
Dalton transactions (Cambridge, England : 2003) (2016) 45, 45 18208-18220
a=14.9292(5)Å b=14.9340(6)Å c=35.2162(12)Å
α=90° β=96.717(2)° γ=90°
C21H19N3O2
C21H19N3O2
Chem.Commun. (2013) 49, 8522
a=14.785(3)Å b=7.1200(14)Å c=17.076(3)Å
α=90.00° β=108.28(3)° γ=90.00°
C38H33N9O8Pt
C38H33N9O8Pt
Chem.Commun. (2013) 49, 8522
a=35.5267(13)Å b=10.0283(4)Å c=21.7394(8)Å
α=90.00° β=101.185(2)° γ=90.00°
C41H30N6O4
C41H30N6O4
The Journal of organic chemistry (2014) 79, 19 9272-9283
a=16.6720(12)Å b=9.9486(7)Å c=18.7198(13)Å
α=90° β=90.02° γ=90°